Bellevue Group AG

Q3 2024 13F-HR Holdings

Location
Kuesnacht, V8
Holdings as of
9/30/2024
Date filed
11/14/2024
Form type
13F-HR
Num holdings
163
Total value ($000)
$6,172,628
Net value change ($000)
+18,299 (0.3%)
New positions
11
Sold out positions
15
Turnover %
0.9%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 8/14/2024 Next filing: 2/14/2025 SEC filing

Snapshot: Change Analysis

Compared to Q2 2024
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
EXAS 49,775 101.7%
ARGX 45,511 15.3%
EVH 43,582 136.5%
CDNA 37,455 61.6%
ABT 31,931 19.1%
BHVN 31,143 44.0%
UNH 27,133 25.9%
RVMD 25,737 13.2%
INSP 24,480 146.7%
BMRN 18,964 441.0%
Top Reduces (Value $000, Stocks/ETFs)
MRNA -78,710 -42.4%
IONS -78,244 -19.9%
DXCM -75,662 -52.6%
NBIX -46,639 -17.8%
EW -41,591 -35.7%
CRL -33,671 -70.0%
INSM -30,097 -44.0%
BIO -26,962 -63.6%
Silk Road Medical Inc -23,127 -100.0%
CNC -21,416 -76.6%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 219 (0.0% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type